Beaton MD - Search Results

1

CYP3A Activity and Expression in Nonalcoholic Fatty Liver Disease.

Woolsey SJ, Mansell SE, Kim RB, Tirona RG, Beaton MD. Woolsey SJ, et al. Among authors: beaton md. Drug Metab Dispos. 2015 Oct;43(10):1484-90. doi: 10.1124/dmd.115.065979. Epub 2015 Jul 31. Drug Metab Dispos. 2015. PMID: 26231377

2

Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Beaton MD. Beaton MD. Can J Gastroenterol. 2012 Jun;26(6):353-7. doi: 10.1155/2012/725468. Can J Gastroenterol. 2012. PMID: 22720278 Free PMC article. Review.

3

Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease.

Beaton MD, Chakrabarti S, Levstik M, Speechley M, Marotta P, Adams P. Beaton MD, et al. Aliment Pharmacol Ther. 2013 Apr;37(7):720-9. doi: 10.1111/apt.12255. Epub 2013 Feb 26. Aliment Pharmacol Ther. 2013. PMID: 23441892 Clinical Trial.

4

Inflammation is not the cause of an elevated serum ferritin in non-alcoholic fatty liver disease.

Beaton MD, Chakrabarti S, Adams PC. Beaton MD, et al. Ann Hepatol. 2014 May-Jun;13(3):353-6. Ann Hepatol. 2014. PMID: 24756010 Free article.

5

Relationships between Endogenous Plasma Biomarkers of Constitutive Cytochrome P450 3A Activity and Single-Time-Point Oral Midazolam Microdose Phenotype in Healthy Subjects.

Woolsey SJ, Beaton MD, Choi YH, Dresser GK, Gryn SE, Kim RB, Tirona RG. Woolsey SJ, et al. Among authors: beaton md. Basic Clin Pharmacol Toxicol. 2016 Apr;118(4):284-91. doi: 10.1111/bcpt.12492. Epub 2015 Oct 14. Basic Clin Pharmacol Toxicol. 2016. PMID: 26399557 Free article.

6

Management of non-alcoholic fatty liver disease in 2015.

Malhotra N, Beaton MD. Malhotra N, et al. Among authors: beaton md. World J Hepatol. 2015 Dec 28;7(30):2962-7. doi: 10.4254/wjh.v7.i30.2962. World J Hepatol. 2015. PMID: 26730275 Free PMC article. Review.

7

Is vitamin e or ursodeoxycholic acid a valid treatment option for nonalcoholic fatty liver disease in 2016?

Beaton MD, Al-Judaibi B. Beaton MD, et al. Saudi J Gastroenterol. 2016 May-Jun;22(3):169-70. doi: 10.4103/1319-3767.182462. Saudi J Gastroenterol. 2016. PMID: 27184632 Free PMC article. No abstract available.

8

A Fibroblast Growth Factor 21-Pregnane X Receptor Pathway Downregulates Hepatic CYP3A4 in Nonalcoholic Fatty Liver Disease.

Woolsey SJ, Beaton MD, Mansell SE, Leon-Ponte M, Yu J, Pin CL, Adams PC, Kim RB, Tirona RG. Woolsey SJ, et al. Among authors: beaton md. Mol Pharmacol. 2016 Oct;90(4):437-46. doi: 10.1124/mol.116.104687. Epub 2016 Aug 1. Mol Pharmacol. 2016. PMID: 27482056

9

Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial.

Joy TR, McKenzie CA, Tirona RG, Summers K, Seney S, Chakrabarti S, Malhotra N, Beaton MD. Joy TR, et al. Among authors: beaton md. World J Gastroenterol. 2017 Jan 7;23(1):141-150. doi: 10.3748/wjg.v23.i1.141. World J Gastroenterol. 2017. PMID: 28104990 Free PMC article. Clinical Trial.

10

HLA-DQA1-HLA-DRB1 polymorphism is a major predictor of azathioprine-induced pancreatitis in patients with inflammatory bowel disease.

Wilson A, Jansen LE, Rose RV, Gregor JC, Ponich T, Chande N, Khanna R, Yan B, Jairath V, Khanna N, Sey M, Beaton M, McIntosh K, Teft WA, Kim RB. Wilson A, et al. Aliment Pharmacol Ther. 2018 Mar;47(5):615-620. doi: 10.1111/apt.14483. Epub 2017 Dec 22. Aliment Pharmacol Ther. 2018. PMID: 29270995

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters